Moderna to use Roche tests in COVID-19 vaccine trials

By The Science Advisory Board staff writers

December 9, 2020 -- Moderna will use Roche's Elecsys anti-SARS-CoV-2 S antibody test in its messenger RNA (mRNA)-1273 vaccine research trials. The test can quantitatively measure the level of antibodies against SARS-CoV-2 in vaccine trial participants.

The companies believe that the test could help to establish a correlation between vaccinations and protection from COVID-19. Moderna's vaccine triggers an antibody response specifically to the anti-receptor binding domain of the SARS-CoV-2 spike protein. Ultimately, the correlation could help Moderna assess if, or when, revaccination would be necessary.


Copyright © 2020 scienceboard.net
 


Email Address:

First Name:

Last Name:

Learn about ScienceBoard

Get the latest life sciences research and industry news, delivered straight to your inbox, for free.

Why subscribe?

ScienceBoard is uniquely focused on the business of research, addressing the biggest problems that the biomedical industry face. You’ll get breaking news, events coverage, and deep dives into the science that drives innovation, delivered to your inbox daily.

I have read and agree to the privacy policy and terms of service and wish to opt-in for ScienceBoard.net.